North America Dialyzer Market

North America Dialyzer Market Size (2023 to 2028)

The North American dialyzer Market was worth USD 1208.87 million in 2023 and is estimated to grow at a CAGR of 6.40%, reaching USD 1648.50 million by 2028.

A dialyzer is a medical device that replaces kidney function by using an artificial membrane to remove excess water and metabolic wastes from the blood. Healthcare professionals primarily use dialyzers for hemodialysis. Patients may need this treatment three to four times a week. The treatment is divided into intermittent hemodialysis treatment and continuity hemodialysis treatment. Renal problems are getting more common in North America. Therefore, Dialyzer adoption is likely to increase due to the rising prevalence of chronic kidney disease and end-stage renal disease, which is expected to be a major growth driver for the North American Dialyzer Market throughout the forecast period. Also, the North America Dialyzer market is growing due to a rise in the number of people suffering from diabetes and hypertension. As the incidence of risk factors associated with the disease, such as diabetes, hypertension, and cancer, rises, end-stage renal disease is expected to become increasingly common. People with chronic illnesses choose dialysis for kidney transplantation because of the hazards of the procedure. 

In addition, the well-established healthcare infrastructure, which offers the necessary technological environment and resources to conduct dialyzer sessions, is expected to aid the growing acceptance of hemodialysis technology. The improved compatibility of high-flux dialyzers with evolving hemodialyzer technologies such as hemodiafiltration and online hemodialysis is likely to fuel the growth of the North American dialyzer market. Other factors, such as the growing geriatric population, changing lifestyles and renal diseases, and awareness and acceptance in emerging countries, are expected to fuel the market growth. Furthermore, favorable reimbursement policies in healthcare are projected to promote the usage of dialyzer equipment over the projection period. One of the driving circumstances is the rise in kidney shortages for transplantation. Therefore, increased funding for improved dialysis goods and services is needed. 

However, the high cost of equipment and maintenance are the major factors restricting the growth of the North American dialyzer market. In addition, challenges associated with hemodialysis procedures, severe anemia, and fluid overload are expected to impede the market growth. 

This research report on the North American dialyzer market has been segmented and sub-segmented into the following categories:

By Type

• High-Flux
• Low-Flux

By End-User

• In Center Dialyzer
• Home Dialyzer

By Country:

• United States
• Canada
• Rest of North America

Geographically, the North American dialyzer market dominated the largest share and is predicted to grow significantly during the forecast period. The regional market growth is projected to be fuelled by advanced healthcare infrastructure, technological advancements in the healthcare sector, and favorable reimbursement policies. In the region, diabetes, hypertension, and end-stage renal disease (ESRD) are all on the rise. The United States and Canada are expanding the regional market growth with a significant market share.

The United States dominated the North American dialyzer market and is more likely to continue its dominance throughout the forecast period. The market growth is attributed to a considerable increase in the incidence of end-stage renal disease (ESRD), hypertension, diabetes, and other disorders in the country. Also, high healthcare spending, technological advancements, and growing awareness about dialysis procedures and equipment further expand the growth of the North American dialyzer market. 

On the other hand, the Canadian Dialyzer market is anticipated to witness a promising share in the coming years owing to the prevalence of renal diseases, chronic diseases, and supportive government policies.  

KEY MARKET PLAYERS:

Asahi Kasei Corp., B. Braun Melsungen AG, Baxter International Inc., Medtronic Plc, JMS Co.Ltd., Kawasumi Laboratories Inc., Fresenius Medical Care AG, Co. KGaA, Nikkiso Co. Ltd., Nipro Corp., Toray Industries Inc. are some of the key players operating in the North America dialyzer market profiled in this report.